Additionally, by inhibiting the activation of the NF-κB and MAPKs pathways, TGP reduces the release of pro-inflammatory cytokines, thereby alleviating inflammation and providing protective effects in SLE. The gene discussed is TGM4; the disease is systemic lupus erythematosus.